These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

700 related items for PubMed ID: 26089551

  • 1. Intraarterial Hepatic SPECT/CT Imaging Using 99mTc-Macroaggregated Albumin in Preparation for Radioembolization.
    Gates VL, Singh N, Lewandowski RJ, Spies S, Salem R.
    J Nucl Med; 2015 Aug; 56(8):1157-62. PubMed ID: 26089551
    [Abstract] [Full Text] [Related]

  • 2. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
    Hamami ME, Poeppel TD, Müller S, Heusner T, Bockisch A, Hilgard P, Antoch G.
    J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
    Kokabi N, Galt JR, Xing M, Camacho JC, Barron BJ, Schuster DM, Kim HS.
    J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
    [Abstract] [Full Text] [Related]

  • 6. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.
    Kao YH, Hock Tan AE, Burgmans MC, Irani FG, Khoo LS, Gong Lo RH, Tay KH, Tan BS, Hoe Chow PK, Eng Ng DC, Whatt Goh AS.
    J Nucl Med; 2012 Apr; 53(4):559-66. PubMed ID: 22343503
    [Abstract] [Full Text] [Related]

  • 7. Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results.
    Garin E, Lenoir L, Rolland Y, Edeline J, Mesbah H, Laffont S, Porée P, Clément B, Raoul JL, Boucher E.
    J Nucl Med; 2012 Feb; 53(2):255-63. PubMed ID: 22302962
    [Abstract] [Full Text] [Related]

  • 8. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.
    Wondergem M, Smits ML, Elschot M, de Jong HW, Verkooijen HM, van den Bosch MA, Nijsen JF, Lam MG.
    J Nucl Med; 2013 Aug; 54(8):1294-301. PubMed ID: 23749996
    [Abstract] [Full Text] [Related]

  • 9. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.
    Ilhan H, Goritschan A, Paprottka P, Jakobs TF, Fendler WP, Todica A, Bartenstein P, Hacker M, Haug AR.
    J Nucl Med; 2015 Nov; 56(11):1654-60. PubMed ID: 26315830
    [Abstract] [Full Text] [Related]

  • 10. Systematic evaluation of tumoral 99mTc-MAA uptake using SPECT and SPECT/CT in 502 patients before 90Y radioembolization.
    Ilhan H, Goritschan A, Paprottka P, Jakobs TF, Fendler WP, Bartenstein P, Hacker M, Haug AR.
    J Nucl Med; 2015 Mar; 56(3):333-8. PubMed ID: 25655623
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Imaging discordance between hepatic angiography versus Tc-99m-MAA SPECT/CT: a case series, technical discussion and clinical implications.
    Kao YH, Tan EH, Teo TK, Ng CE, Goh SW.
    Ann Nucl Med; 2011 Nov; 25(9):669-76. PubMed ID: 21766243
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Angiography-based C-arm CT for the assessment of extrahepatic shunting before radioembolization.
    Heusner TA, Hamami ME, Ertle J, Hahn S, Poeppel T, Hilgard P, Bockisch A, Forsting M, Antoch G.
    Rofo; 2010 Jul; 182(7):603-8. PubMed ID: 20183775
    [Abstract] [Full Text] [Related]

  • 15. Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
    Garin E, Rolland Y, Edeline J, Icard N, Lenoir L, Laffont S, Mesbah H, Breton M, Sulpice L, Boudjema K, Rohou T, Raoul JL, Clement B, Boucher E.
    J Nucl Med; 2015 Mar; 56(3):339-46. PubMed ID: 25678490
    [Abstract] [Full Text] [Related]

  • 16. Outpatient single-session yttrium-90 glass microsphere radioembolization.
    Gates VL, Marshall KG, Salzig K, Williams M, Lewandowski RJ, Salem R.
    J Vasc Interv Radiol; 2014 Feb; 25(2):266-70. PubMed ID: 24332243
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres.
    Prince JF, van Rooij R, Bol GH, de Jong HW, van den Bosch MA, Lam MG.
    J Nucl Med; 2015 Jun; 56(6):817-23. PubMed ID: 25931477
    [Abstract] [Full Text] [Related]

  • 20. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
    Burgmans MC, Kao YH, Irani FG, Dames EL, Teo TK, Goh AS, Chow PK, Tay KH, Lo RH.
    J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.